GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Accounts Payable

SK Bioscience Co (XKRX:302440) Accounts Payable : ₩17,818 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Accounts Payable?

SK Bioscience Co's Accounts Payable for the quarter that ended in Dec. 2024 was ₩17,818 Mil.

SK Bioscience Co's quarterly Accounts Payable increased from Jun. 2024 (₩11,386 Mil) to Sep. 2024 (₩12,960 Mil) and increased from Sep. 2024 (₩12,960 Mil) to Dec. 2024 (₩17,818 Mil).

SK Bioscience Co's annual Accounts Payable declined from Dec. 2022 (₩11,053 Mil) to Dec. 2023 (₩3,370 Mil) but then increased from Dec. 2023 (₩3,370 Mil) to Dec. 2024 (₩17,818 Mil).

SK Bioscience Co Accounts Payable Historical Data

The historical data trend for SK Bioscience Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Accounts Payable Chart

SK Bioscience Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial 17,505.19 63,811.95 11,053.23 3,370.14 17,817.55

SK Bioscience Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,370.14 8,527.03 11,385.66 12,959.67 17,817.55

SK Bioscience Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

SK Bioscience Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Accounts Payable
Comparable Companies
XKRX:141080 XKRX:214450 XKRX:145020 XKRX:950160 XKRX:087010 XKRX:310210 XKRX:298380 XKRX:096530 XKRX:086900 XKRX:950210 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
Website
https://www.skbioscience.co.kr
SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co Headlines

No Headlines